Actinogen anticipates final topline efficacy and safety results for the full 36-week treatment period in November 2026.

Discover how AI is reshaping Alzheimer’s and dementia care through early detection, faster clinical trials, and improved ...

Vitamin D may be a potentially modifiable factor to reduce dementia risk, study suggests ...

Mary Beth Hurt, known for her performances in "Interiors" and "The World According to Garp," has died at 79.

Autopsy shows widespread amyloid and tau in patient who received contaminated biological m ...

Dear Abby: I have been friends with my neighbor “Mary” for 30 years. She has developed Alzheimer’s disease and needs constant ...

A proprietary monoclonal antibody targeting an inhibitory immune checkpoint pathway had favorable safety and tolerability in ...

For the millions of people who carry the gene APOE4, the strongest known genetic risk factor for Alzheimer's disease, their brain activity may begin ...

A simple nasal swab may offer an unexpected window into the earliest biological signals of Alzheimer’s disease.

The risk of Alzheimer's disease significantly decreases in older adults who receive a higher dose of the influenza vaccine ...

The National Institutes of Health has renewed support for Artificial Intelligence for Alzheimer’s Disease, or AI4AD. The new ...

Carolina McCalmon, a physician assistant with Novant Health Neurology Department, was in the studio to talk more about ways ...